Education
About Us
Working with TipRanks
Follow Us
Innocan Pharma Corporation (INNPF)
:INNPF
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 29.44M | $ 13.66M | $ 2.56M | $ 196.00K | $ 8.00K |
| Gross Profit | $ 26.19M | $ 11.98M | $ 2.11M | $ 121.00K | $ 3.00K |
| Operating Income | $ -1.25M | $ 3.80M | $ -6.27M | $ -7.48M | $ -4.72M |
| EBITDA | $ 961.00K | $ -3.77M | $ -3.85M | $ -10.04M | $ -9.90M |
| Net Income | $ -1.83M | $ -4.70M | $ -3.89M | $ -10.06M | $ -15.18M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.01M | $ 3.88M | $ 4.95M | $ 11.05M | $ 2.34M |
| Total Assets | $ 9.26M | $ 6.94M | $ 6.98M | $ 12.57M | $ 4.33M |
| Total Debt | $ 10.00K | $ 33.00K | $ 34.00K | $ 1.00K | $ 38.00K |
| Net Debt | $ -5.00M | $ -3.85M | $ -4.91M | $ -11.05M | $ -2.30M |
| Total Liabilities | $ 2.24M | $ 2.55M | $ 751.00K | $ 3.56M | $ 7.94M |
| Stockholders' Equity | $ 5.17M | $ 4.10M | $ 6.39M | $ 9.05M | $ -3.61M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.59M | $ -3.95M | $ -6.09M | $ -6.67M | $ -3.69M |
| Operating Cash Flow | $ -1.58M | $ -3.90M | $ -6.07M | $ -6.63M | $ -3.69M |
| Investing Cash Flow | $ 54.00K | $ -84.00K | $ -31.00K | $ -48.00K | $ 0.00 |
| Financing Cash Flow | $ 2.70M | $ 2.92M | $ 125.00K | $ 15.30M | $ 4.02M |
InnoCan Pharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.